Insights

Strategic Geographic Focus Allergy Therapeutics has a strong commercial presence in Europe with active plans to expand into the US market, presenting opportunities to partner on distribution, licensing, or joint ventures to accelerate market entry and growth.

Pipeline Innovation The company's ongoing clinical development of allergy vaccines for grass, tree, dust mite, and peanut allergies, along with research into adjuvant systems, offers prospects for collaborative research, licensing deals, and early-stage product placements.

Recent Funding Boost With recent financing rounds totaling over $125 million, Allergy Therapeutics is well-capitalized to invest in sales expansion, marketing efforts, and strategic alliances, providing scope for expanding outreach and market penetration.

Industry Engagement Participation in prominent conferences like AAAAI/WAO indicates active engagement with the allergy and immunology community, which can be leveraged to build relationships with key healthcare providers and thought leaders.

Technology and Innovation The company's focus on vaccine adjuvant systems and innovative allergy treatments suggests potential opportunities to introduce cutting-edge therapies to healthcare providers seeking novel solutions, broadening the product portfolio's appeal.

Similar companies to Allergy Therapeutics

Allergy Therapeutics Tech Stack

Allergy Therapeutics uses 8 technology products and services including CIVIC, Google Fonts API, jQuery, and more. Explore Allergy Therapeutics's tech stack below.

CIVIC
Cookie Compliance
Google Fonts API
Font Scripts
jQuery
Javascript Libraries
Microsoft Azure
Platform As A Service
X-XSS-Protection
Security
X-Content-Type-Options
Web & Portal Technology
Google Analytics
Web Analytics
AddToAny
Widgets

Media & News

Allergy Therapeutics's Email Address Formats

Allergy Therapeutics uses at least 1 format(s):

Allergy Therapeutics Email Formats	Example	Percentage
First.Last@allergytherapeutics.com	John.Doe@allergytherapeutics.com	90%
First.Middle@allergytherapeutics.com	John.Michael@allergytherapeutics.com	4%
FirstLast@allergytherapeutics.com	JohnDoe@allergytherapeutics.com	4%
FLast@allergytherapeutics.com	JDoe@allergytherapeutics.com	2%

Frequently Asked Questions

Where is Allergy Therapeutics's headquarters located?

Allergy Therapeutics's main headquarters is located at Dominion Way, Worthing, West Sussex BN14 8SA, GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Allergy Therapeutics's phone number?

You can contact Allergy Therapeutics's main corporate office by phone at

+44-1903-84****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Allergy Therapeutics's official website and social media links?

Allergy Therapeutics's official website is allergytherapeutics.com and has social profiles on LinkedIn Crunchbase.

What is Allergy Therapeutics's NAICS code?

Allergy Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Allergy Therapeutics have currently?

As of October 2025, Allergy Therapeutics has approximately 501 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer: S. F. F.Chief Information Security Officer: G. M.Chief Scientific Officer: M. S.. Explore Allergy Therapeutics's employee directory with LeadIQ.

What industry does Allergy Therapeutics belong to?

Allergy Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Allergy Therapeutics use?

Allergy Therapeutics's tech stack includes CIVICGoogle Fonts APIjQueryMicrosoft AzureX-XSS-ProtectionX-Content-Type-OptionsGoogle AnalyticsAddToAny.

What is Allergy Therapeutics's email format?

Allergy Therapeutics's email format typically follows the pattern of First.Last@allergytherapeutics.com. Find more Allergy Therapeutics email formats with LeadIQ.

When was Allergy Therapeutics founded?

Allergy Therapeutics was founded in 1998.

Allergy Therapeutics

Pharmaceutical ManufacturingUnited Kingdom501-1000 Employees

Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments. We have a well-established commercial presence in Europe and are focused on the US market. 

We specialise in the diagnosis and treatment of allergy. We mainly sell our products in European countries and our pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, as well as a peanut allergy vaccine in pre-clinical development.

Adjuvant systems to boost performance of vaccines outside of allergy are also under evaluation.